On the public citation graph
Synthesis and Biological Evaluation of a Novel Series of “Ortho-Nitrated” Inhibitors of Catechol- O -methyltransferase
0 signed · 54 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ana.410030314openalex-snapshot
A double‐blind comparison of levodopa, madopa, and sinemet in Parkinson disease
inferredcites →https://doi.org/10.1002/hlca.19890720511openalex-snapshot
Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity Studies
inferredcites →https://doi.org/10.1007/bf00199880openalex-snapshot
Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone
inferredcites →https://doi.org/10.1007/s00228-003-0680-5openalex-snapshot
Pharmacokinetic?pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide
inferredcites →https://doi.org/10.1007/s00726-001-0111-9openalex-snapshot
L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent
inferredcites →https://doi.org/10.1016/0165-6147(89)90075-8openalex-snapshot
New selective COMT inhibitors: useful adjuncts for Parkinson's disease?
inferredcites →https://doi.org/10.1016/0165-6147(89)90076-xopenalex-snapshot
Drugs interacting with 5-HT systems show promise for treatment of eating disorders
inferredcites →https://doi.org/10.1016/0304-3940(91)90422-popenalex-snapshot
The significance of 3-O-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease
inferredcites →https://doi.org/10.1016/j.ejps.2005.01.005openalex-snapshot
The role of physicochemical properties of entacapone and tolcapone on their efficacy during local intrastriatal administration
inferredcites →https://doi.org/10.1016/s0014-2999(97)01431-3openalex-snapshot
Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production
inferredcites →https://doi.org/10.1016/s0022-3565(24)36880-6openalex-snapshot
Studies on the Tight-Binding Nature of Tolcapone Inhibition of Soluble and Membrane-Bound Rat Brain Catechol-O-Methyltransferase
inferredcites →https://doi.org/10.1016/s0028-3908(99)00042-8openalex-snapshot
Interaction between l-DOPA and 3-O-methyl-l-DOPA for transport in immortalised rat capillary cerebral endothelial cells
inferredcites →https://doi.org/10.1016/s0140-6736(05)61511-5openalex-snapshot
Tolcapone and fulminant hepatitis
inferredcites →https://doi.org/10.1021/jm00102a011openalex-snapshot
Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors
inferredcites →https://doi.org/10.1021/jm00124a017openalex-snapshot
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors
inferredcites →https://doi.org/10.1021/jm0109964openalex-snapshot
Synthesis of 1-(3,4-Dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and Derivatives as Potent and Long-Acting Peripheral Inhibitors of Catechol-O-methyltransferase
inferredcites →https://doi.org/10.1021/jm040848oopenalex-snapshot
Synthesis, Biological Evaluation, and Molecular Modeling Studies of a Novel, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
inferredcites →https://doi.org/10.1038/sj.bjp.0702474openalex-snapshot
In vivo effects of new inhibitors of catechol‐O‐methyl transferase
inferredcites →https://doi.org/10.1056/nejm196702162760703openalex-snapshot
Aromatic Amino Acids and Modification of Parkinsonism
inferredcites →https://doi.org/10.1081/scc-120002413openalex-snapshot
IMPROVED METHOD FOR DEMETHYLATION OF NITRO- CATECHOL METHYL ETHERS
inferredcites →https://doi.org/10.1097/00002826-198406001-00047openalex-snapshot
MIDBRAIN DOPAMINERGIC NEURONS
inferredcites →https://doi.org/10.1097/00002826-200401000-00007openalex-snapshot
Pharmacokinetic–Pharmacodynamic Interaction Between BIA 3-202, a Novel COMT Inhibitor, and Levodopa/Carbidopa
inferredcites →https://doi.org/10.1097/00002826-200405000-00006openalex-snapshot
Frequency, Reasons, and Risk Factors of Entacapone Discontinuation in Parkinson Disease
inferredcites →https://doi.org/10.1107/s0108767305082085openalex-snapshot
Experimental electron density of [Cu(phen)2Cl](NO3)(H2O)
inferredcites →https://doi.org/10.1107/s0907444901006539openalex-snapshot
Crystallization and preliminary crystallographic characterization of catechol-O-methyltransferase in complex with its cosubstrate and an inhibitor
inferredcites →https://doi.org/10.1111/j.1600-0773.1990.tb00756.xopenalex-snapshot
Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease
inferredcites →https://doi.org/10.1124/dmd.31.3.250openalex-snapshot
Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
inferredcites →https://doi.org/10.1124/mol.62.4.795openalex-snapshot
Kinetics and Crystal Structure of Catechol-O-Methyltransferase Complex with Co-Substrate and a Novel Inhibitor with Potential Therapeutic Application
inferredcites →https://doi.org/10.1172/jci106831openalex-snapshot
Peripheral Aromatic L-Amino Acids Decarboxylase Inhibitor in Parkinsonism. I. EFFECT ON O-METHYLATED METABOLITES OF L-DOPA-2-14C
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9781119143802.ch66openalex-snapshot
Neuroprotective Compounds from Marine Microorganisms
inferred← citeshttps://doi.org/10.1002/bmc.1377openalex-snapshot
Assessment of COMT isolation by HIC using a dual salt system and low temperature
inferred← citeshttps://doi.org/10.1002/qsar.200730053openalex-snapshot
A 3‐D QSAR Study of Catechol‐O‐Methyltransferase Inhibitors Using CoMFA and CoMSIA
inferred← citeshttps://doi.org/10.1016/b978-0-12-381326-8.00005-3openalex-snapshot
Biochemistry and Pharmacology of Catechol-O-Methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-381326-8.00006-5openalex-snapshot
The Chemistry of Catechol-O-Methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-823974-2.00029-2openalex-snapshot
Catechol-O-methyltransferase (COMT)
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103418openalex-snapshot
Neurological and psychiatric management using COMT inhibitors: A review
inferred← citeshttps://doi.org/10.1016/j.comptc.2016.01.003openalex-snapshot
Ab initio study of electronic interaction energies and desolvation energies for dopaminergic ligands in the catechol-O-methyltransferase active site
inferred← citeshttps://doi.org/10.1016/j.jmb.2008.04.040openalex-snapshot
Crystal Structures of Human 108V and 108M Catechol O-Methyltransferase
inferred← citeshttps://doi.org/10.1016/j.lfs.2015.04.026openalex-snapshot
Effect of intracerebral hydroxytyrosol and its nitroderivatives on striatal dopamine metabolism: A study by in vivo microdialysis
inferred← citeshttps://doi.org/10.1021/acs.jafc.6b00401openalex-snapshot
Evaluation of the Bioavailability and Metabolism of Nitroderivatives of Hydroxytyrosol Using Caco-2 and HepG2 Human Cell Models
inferred← citeshttps://doi.org/10.1021/acsomega.2c05518openalex-snapshot
Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors
inferred← citeshttps://doi.org/10.1021/jm1001524openalex-snapshot
Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1021/jm500572bopenalex-snapshot
Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
inferred← citeshttps://doi.org/10.1039/9781849737357-00083openalex-snapshot
Catechol‐O‐Methyl‐Transferase Inhibitors: Present Problems and Relevance of the New Ones
inferred← citeshttps://doi.org/10.1039/d4fb00126eopenalex-snapshot
Exploring natural chalcones: innovative extraction techniques, bioactivities, and health potential
inferred← citeshttps://doi.org/10.1080/00397910701821077openalex-snapshot
Convenient Synthesis of Tolcapone, a Selective Catechol‐O‐methyltransferase Inhibitor
inferred← citeshttps://doi.org/10.1111/j.1527-3458.2007.00020.xopenalex-snapshot
Catechol‐ O ‐methyltransferase and Its Inhibitors in Parkinson's Disease
inferred← citeshttps://doi.org/10.1111/j.2042-7158.2011.01278.xopenalex-snapshot
In-vivo evaluation of prolonged release bilayer tablets of anti-Parkinson drugs in Göttingen minipigs
inferred← citeshttps://doi.org/10.1124/mol.106.023119openalex-snapshot
Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation
inferred← citeshttps://doi.org/10.3390/antiox12101853openalex-snapshot
Quinoline Derivatives: Promising Antioxidants with Neuroprotective Potential
inferred← citeshttps://doi.org/10.3390/ijms232113246openalex-snapshot
CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.